Search Results
Found 2 results
510(k) Data Aggregation
(120 days)
The Misonix Inc. neXus® Utrasonic Surgical Aspirator System is intended for the fragmentation, emulsification and aspiration of both soft and hard (i.e.bone) tissue.
The indications for use for the Standard Handpiece in combination with BoneScalpel® and SonicOne® OR probe kit accessory configurations and the indications for the SonaStar® long and short handpiece in combination with SonaStar® probe kit accessory configurations are listed below.
Standard Handpiece with BoneScalpel Probe Kits
Indicated for use in the fragmentation of soft and hard (e.g.: bone) tissue in the following surgical specialties:
- · Neurosurgery
- · Gastrointestinal and Affiliated Organ Surgery
- · Urological Surgery
- · Plastic and Reconstructive Surgery
- · General Surgery
- · Orthopedic Surgery
- · Gynecology
External genitalia - condyloma - benign tumors (lipomas, and leiomyomas) - malignant primary and metastatic tumors of all types and the following cystic lesions: Bartholin's cysts, Vestibular adenitis, Inclusion cysts, Sebaceous cysts
Abdominal area - any abnormal growth, cystic or solid, benign or malignant, involving the ovary, fallopian tube, uterus, or the supporting structures of the uterus except as contraindicated for uterine fibroids.
· Thoracic Surgery
Limited pulmonary reception such as segmetectomies, nonanatomical subsegmentectomies and metastatectomies.
· Wound Care
Indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.
Standard Handpiece with SonicOne Probe Kits
Indicated for use in the fragmentation of soft and hard tissue (i.e. bone) in the following surgical specialty: · Wound Care
The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.
Standard Handpiece with SonicOne Probe Kits
Indicated for use in the fragmentation of soft and hard tissue (i.e. bone) in the following surgical specialty: · Wound Care
The neXus Ultrasonic Surgical Aspirator is also indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers, bedsores and vaginal ulcers, soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement. · Plastic and Reconstructive Surgery
Long SonaStar Handpiece & Short SonaStar Handpiece with SonaStar Probe Kits Indicated for use in the fragmentation, emulsification and aspiration of both soft and hard (i.e. bone) tissue in the following surgical specialties:
- · Neurosurgery
- · Gastrointestinal and Affiliated Organ Surgery
- · Urological Surgery
- · Plastic and Reconstructive Surgery General Surgery
- · Orthopedic Surgery
- · Gynecological Surgery except as contraindicated for uterine fibroids.
- · Thoracic Surgery
- · Laparoscopic Surgery
- · Thoracoscopic Surgery
The SonaStar Handpieces may also be combined with electrosurgery using optional RF surgery interface components.
The neXus® Ultrasonic Surgical Aspirator System is intended for fragmentation, emulsification and aspiration of both soft and hard (i.e.bone) tissue. The system includes a generator housed inside the console. A reusable handpiece is plugged directly into the front panel of the console. The generator and handpiece are compatible with various single use disposable "probes" which are selected and attached to the handpiece by the end user. An irrigation unit provides sterile irrigant to the operative site. An aspiration system removes the fragmented, emulsified material and waste liquids from the operative site. Accessories include a wireless footswitch, various probe tip combinations, sterilization trays, probe covers, assembly & disassembly wrenches, irrigation tubing sets, and waste collection canisters.
The document provided is a 510(k) Pre-Market Notification from the FDA regarding the Misonix Inc. neXus® Ultrasonic Surgical Aspirator System. This type of submission focuses on demonstrating substantial equivalence to a legally marketed predicate device, rather than proving efficacy from new clinical studies. Therefore, much of the information typically found in a study proving a device meets acceptance criteria for an AI/ML product (e.g., sample size for test sets, number of experts for ground truth, MRMC studies, standalone performance, training set details) will not be present.
Instead, the acceptance criteria here relate to demonstrating that the neXus Ultrasonic Surgical Aspirator System is as safe and effective as its predicate devices. The "study" referenced in the document is a series of performance tests and compliance checks against various standards.
Here's a breakdown of the requested information based on the provided document:
1. Table of Acceptance Criteria and Reported Device Performance
Given the nature of the 510(k) submission, "acceptance criteria" are generally compliance with recognized standards and a demonstration that the device's technological characteristics are comparable to the predicate devices and that the device performs as intended. The "reported device performance" are the results of various internal and external tests that affirm this.
Acceptance Criteria Category | Specific Criteria (from standards or comparison) | Reported Device Performance |
---|---|---|
Biocompatibility | Compliance with ISO 10993 series for patient and fluid path contacting components. | Biocompatibility testing (Cytotoxicity, Irritation, Sensitization, System Toxicity, Pyrogenicity) was performed in accordance with ISO 10993-1, -5, -7, -10, -11, -12, and the results "demonstrate that the patient and fluid path contacting materials are biocompatible." |
Sterilization & Shelf Life | Compliance with FDA guidance for sterile device submissions; demonstration of sterility and performance after sterilization and aging. | Submission included required sterilization information. Sterile barrier testing and device performance testing on sterilized and accelerated aged devices supported a shelf life of 3 months for single-use disposables. Validated instructions for cleaning and sterilization, and expected use life, are provided for reusable components. |
Electrical Safety & EMC | Compliance with ANSI/AAMI/ES 60601-1, IEC 60601-2-2, and IEC 60601-1-2 standards. | Electrical safety and EMC testing were conducted. Test results "demonstrate that the neXus system meets the applicable requirements for this device type." |
Software V&V | Compliance with FDA's "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" for a "major" level of concern software. | Software verification and validation testing were conducted. Documentation was provided, and test results "demonstrate that the neXus system has been fully verified and validated for its intended use." The software was considered "major" level of concern. |
Bench Performance | Device meets all specifications and requirements met by predicate devices for ultrasound, irrigation, aspiration, RF compatibility, and wireless coexistence. | Performance testing "demonstrated that the device continues to meet all of the specifications and requirements that were met by the predicate devices" for: Ultrasound Performance, Irrigation Performance, Aspiration Performance, OEM RF Compatibility, and Wireless Coexistence Testing. Specifications for vibration system, irrigation pump flow rate, and vacuum pump flow rate are detailed and compared to predicates. |
Substantial Equivalence | Indications for use and technological features are equivalent to predicate devices, and do not raise new questions of safety or effectiveness. | The indications for use are equivalent, and the technological comparisons (Table 1 and following text) show similar characteristics or improvements that do not raise new safety/effectiveness concerns. |
2. Sample size used for the test set and the data provenance
- Test Set Sample Size: Not applicable. The document describes engineering and regulatory compliance testing rather than a clinical study with a patient test set in the context of an AI/ML algorithm. The "test set" here would refer to the specific device units and components undergoing the various bench, electrical, and biocompatibility tests.
- Data Provenance: Not applicable. The data is generated from internal testing and validation processes conducted by the manufacturer (Misonix Inc.) to demonstrate compliance with standards and equivalence.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
- Not applicable. This is not a study requiring expert readers to establish ground truth for image interpretation or diagnosis. The "ground truth" for this device is its performance against engineering specifications and its compliance with regulatory standards, which is assessed through laboratory testing and comparisons to predicate devices.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Not applicable. Adjudication methods like 2+1 or 3+1 are typically used in clinical studies for diagnostic accuracy, especially when establishing ground truth from multiple expert readings. This document reports on device performance and safety testing.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, if so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable. This is a traditional medical device (ultrasonic surgical aspirator) without an AI component described in the submission. Therefore, no MRMC study comparing human readers with and without AI assistance was conducted or would be relevant.
6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done
- Not applicable. As noted, this device is an ultrasonic surgical aspirator, not an AI/ML algorithm.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)
- The "ground truth" for this submission is based on engineering specifications, regulatory standards compliance, and direct comparisons to the established performance and characteristics of predicate devices. For biocompatibility, the ground truth is defined by the parameters and pass/fail criteria of the ISO 10993 standards. For electrical safety, it's the limits set by IEC 60601 standards. For functional performance, it is meeting the specifications equivalent to or better than the predicate devices.
8. The sample size for the training set
- Not applicable. This is not an AI/ML device that requires a training set.
9. How the ground truth for the training set was established
- Not applicable. As this device does not involve an AI/ML component or a training set, this question is not relevant.
Ask a specific question about this device
The Misonix SonicOne Ultrasonic Would Care System and Accessories are indicated for use in the debridement of wounds, such as, but not limited to, burn wounds, diabetic ulcers. bedsores and vaginal ulcers. soft tissue debridement and cleansing of the surgical site in applications in which, in the physician's judgment would require the use of an ultrasonic aspirator with sharp debridement.
The SonicOne Plus Ultrasonic Wound Care System and Accessories is comprised of a generator, which feeds a 22.5 kHz electrical signal to a piezoelectric crystals mounted in a hand-held handpiece; the crystals then vibrate at the same frequency. The titanium tip attached to the handpiece amplifies the vibration. An irrigation unit is provided to introduce irrigation solution to the operative site. Accessories include Probe tips, Wrenches, Sterile and non sterile Tube sets and sterile Surgical Procedure bags and sterile Handpiece Sheaths.
This document describes the Misonix SonicOne Plus Ultrasonic Wound Care System and Accessories, which is an ultrasonic surgical system used for wound debridement. The submission aims to demonstrate substantial equivalence to predicate devices, namely the SonicOne Ultrasonic Wound Care System (K112782) and the AUSS-7 Ultrasonic Surgical System (K070313).
Here's an analysis of the provided information:
1. Table of Acceptance Criteria and Reported Device Performance
The acceptance criteria for this device are based on compliance with a set of voluntary standards and successful completion of non-clinical tests. The "reported device performance" is essentially the statement that the device has "passed" these standards and tests. There are no specific quantitative performance metrics like sensitivity, specificity, or accuracy provided, as this is a medical device for physical intervention, not diagnostic imaging or AI.
Acceptance Criteria (Voluntary Standards & Non-Clinical Tests) | Reported Device Performance |
---|---|
UL 60601-1 2nd Edition (Medical Electrical Equipment, Part 1: General Requirements for Safety) | Passed |
IEC 60601-1* 2nd Edition (Medical Electrical Equipment, Part 1: General Requirements for Safety) | Passed |
ISO 10993-1:2009 (Biological evaluation of medical devices —Part 1: Evaluation and testing) | Passed |
ISO 10993-7:2008 (Biological evaluation of medical devices Part 7: Ethylene oxide sterilization residuals) | Passed |
ISO 14971:2007 (Medical devices -- Application of risk management to medical devices) | Passed |
ISO 15223-1:2007/A1:2008 (Medical devices—Symbols to be used with medical device labels, labeling, and information to be supplied—Part 1: General requirements) | Passed |
ISO 11607:2006 (Packaging for Terminally Sterilized Medical Devices) | Passed |
ISO 11135:2007 (Sterilization of health care products -- Ethylene oxide -- Part 1: Requirements for development, validation and routine control of a sterilization process for medical devices) | Passed |
IEC 62304: 2006 (Medical Device Software-Software Life Cycle Processes) | Passed |
IEC 60601-1-4 (General Requirements for safety-Programmable electrical medical systems) | Passed |
FCC Part 18 (EMC Requirements) | Passed |
Output Frequency Measurements | Performed |
Output Power Measurements (No Load to Maximum Load) | Performed |
Tip Displacement Measurements | Performed |
Irrigation Flowrate Measurements | Performed |
Life Tests | Performed |
Input Power Measurements | Performed |
EMI Tests | Performed |
Dielectric Tests on Mains Circuits | Performed |
Patient Current Leakage and Patient Sink Current Measurements | Performed |
Power Line Ground Leakage Measurements | Performed |
Dielectric Tests on Patient Circuits | Performed |
Sterilization Validations (ANSI/AAMI/ISO 11135:1994 or latest and ISO 11135:2007) | Validated |
Reprocessing (cleaning/disinfecting/sterilization) instructions validation | Validated |
Software Validation (cleared under FDA 510k #K070313, meets FDA guideline "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices" and ISO 60601-1-4) | Cleared and Meets Requirements |
2. Sample Size Used for the Test Set and the Data Provenance
The document explicitly states: "As such, no additional clinical data was obtained in anticipation of this submission." This indicates that there was no dedicated test set involving human subjects or clinical data for this specific 510(k) submission. The safety and performance assessment relies on non-clinical tests, engineering validations, and substantial equivalence to previously cleared predicate devices.
3. Number of Experts Used to Establish the Ground Truth for the Test Set and the Qualifications of Those Experts
Not applicable. There was no clinical test set requiring ground truth establishment by experts for this submission. The device's safety and effectiveness are established through engineering and biological testing against established standards.
4. Adjudication Method (e.g., 2+1, 3+1, none) for the Test Set
Not applicable. There was no clinical test set requiring adjudication.
5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, If so, What Was the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance
Not applicable. This device is an ultrasonic surgical system, not an AI-powered diagnostic or assistive tool for human readers. Therefore, an MRMC comparative effectiveness study regarding "human readers improve with AI" is irrelevant.
6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done
Not applicable. This is a physical medical device, not an algorithm.
7. The Type of Ground Truth Used (expert consensus, pathology, outcomes data, etc.)
The "ground truth" for this device's performance is established by engineering standards and biological safety standards (e.g., ISO, IEC, UL, FCC for electrical safety, biocompatibility, sterilization, and electromagnetic compatibility). For the software component, the ground truth is its compliance with FDA guidelines and ISO 60601-1-4, as validated by previous clearance (K070313).
8. The Sample Size for the Training Set
Not applicable. The device is not an AI algorithm that requires a training set in the typical sense. Its design and operational parameters are based on established engineering principles and its predicate devices.
9. How the Ground Truth for the Training Set Was Established
Not applicable. No training set for an AI algorithm was used.
Ask a specific question about this device
Page 1 of 1